chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Beginning the evening of December 2, 2022, and for the following three nights, I had high fevers that were as high as 103-degrees and severe right-sided pleuritic chest pain. I had flown out of state for an event. The pain went away after returning home. I didn't seek medical attention then. Aside from low-grade fevers, I had no other symptoms over the next two weeks. On December 19, 2022, I flew out of state. The chest pain reoccurred while I was out of state. Upon returning home on December 21, 2022, I started coughing up a lot of blood. On December 22, 2022, my doctor order a CT Angiogram. I was found to have Bilateral Pulmonary Emboli as well as right-sided pleural infusion and an infarcted right lower lobe. No source for the emboli was found. My ultrasounds of my lower extremities were negative. I was admitted to the hospital on December 22, 2022. I stayed in the hospital about 36 hours and was discharged on December 24, 2022, after being started on anticoagulants. It took about two months to recover.
Fever, chills, body ache, joint pain first 24 hours Sore throat and new sore on toungue  day two
24 hrs after administration had T=102.6 and con't to spike fevers > 101.5 x 48 hrs. After temps subsided had myalgias x 24 hrs and gen. fatigue x 5-6 days. Last year spiked fevers to 101 24 hours after flu vaccine.
a red area lump at vaccine site; that area only had a 101°F temperature; 2 inch red rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (a red area lump at vaccine site), VACCINATION SITE WARMTH (that area only had a 101°F temperature) and VACCINATION SITE RASH (2 inch red rash) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A or 037K2DA) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE MASS (a red area lump at vaccine site), VACCINATION SITE WARMTH (that area only had a 101°F temperature) and VACCINATION SITE RASH (2 inch red rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Adverse event, at a dose of 1 dosage form. On 28-Jan-2021, VACCINATION SITE MASS (a red area lump at vaccine site), VACCINATION SITE WARMTH (that area only had a 101°F temperature) and VACCINATION SITE RASH (2 inch red rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Muscle fatigue started around 8am. Temperature started to raise shortly after and sweating began. Symptoms stabilized  until around 7pm. Severe sweating and chills through the next night.   Muscle fatigue continued the next day.
6 hrs post vax devel flu-like sx, inc temp, arthralgia; 12 hrs post vax devel resp distress/asthma like sx; 24 hrs post/vax devel mod edema in lt arm (inj site) edema progressed to both lower extremities & has not resolved;
Sore at injection site. 5 hours after injection, i had an Increased heart rate, 101 fever,  convulsing from the chills, body aches, poor sleep. splitting headache, fatigue, and fever continued to next day. Most symptoms were gone by 48 hours after injection, except soreness around arm.  Took ibuprofen to help with symptoms.
No other adverse effects were reported; patient received an expired PROQUAD dose; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were unknown. Concomitant therapies included sterile diluent (STERILE DILUENT).  On 19-JUN-2020, the patient was vaccinated with an expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA), injection, lot # R026362, expiration date 15-MAR-2020, 1 dosage form (strength, exact dose and route of administration were not reported) for prophylaxis. No other adverse effects were reported. The outcome of the events was unknown.
pt recv vax 3APR98 & on 13APR98morning devel skin rashes by afternoon devel fever of 103 on 14APR98 fever had gone down;skin rash got worse & covered chest, face, back, extremities;14APR98 T99.1;
AFTER 48 HOURS OF RECEIVING THE MODERNA 1ST INJECTION I EXPERIENCED SEVERE DIARRHEA AND TENESMUS LEADING TO LOW ABDOMINAL CRAMPS AND THIS LASTED FOR 2 DAYS UNTIL MONDAY MORNING 07:00.  THE TENESMUS WITH SEVERE WITH RECTAL IRRITATION AND NOTED BLOOD ON TOILET TISSUE.  RESOLUTION CAME AFTER THE 07:00 MONDAY MORNING WITH MILDER SYMPTOMS SIMILAR THE FOLLOWING SATURDAY 7 DAYS FROM THE INITIAL ONSET OF THE SEVERE EPISODE OF DIARRHEA.
Swelling and redness to back of left arm. Patient states he has had fever after receiving vaccine but took OTC Tylenol and symptoms resolved. Patient states swelling has increased to left arm and complains of soreness and itching to site.  Patient advised to be seen at Emergency Department. Patient states he has appointment with PCM and will have site examined.
Red rash around a hardened center "bump". Patient is stating the pain is still there as of 03-14-2021 and the rash has not receeded at all.
30 hours after receiving the immunization, patient developed HA, diarrhea, chills, general body aches. These symptoms subsided but patient noticed a purple rash to his lower extremities, swelling and stiffness in his hands, ankles, R elbow. Petechial/purpuric rash noted to BLE at follow up office visit on 3/19 with 1+ pitting edema to L ankle. Edema noted to bilateral hands.
is menstruating and she has cramps and they're strong; she is menstruating; This spontaneous case was reported by a consumer and describes the occurrence of DYSMENORRHOEA (is menstruating and she has cramps and they're strong) and MENSTRUAL DISORDER (she is menstruating) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Oct-2021, the patient experienced DYSMENORRHOEA (is menstruating and she has cramps and they're strong) and MENSTRUAL DISORDER (she is menstruating). At the time of the report, DYSMENORRHOEA (is menstruating and she has cramps and they're strong) and MENSTRUAL DISORDER (she is menstruating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product reported by reporter. No treatment medication reported by reporter.
Right after vaccines were given pt cried out while mom buttoned his pants. When mom picked the child up he stopped crying and stiffened up. Pt. was pale in color, pt. eyes were fixed upwards and to the left, limbs were stiff and arm straight in front of him. Pt was breathing but no response to stimulation. This lasted 1 minute. No other symptoms after.
The patient noticed redness and swelling which grew significantly over the two days following receiving the vaccination. She went to her primary care provider and they gave the patient a prescription for a methylprednisolone dose pack to decrease the inflammation. They did not believe there was a secondary infection at this time. The event was brought to our attention immediately after the doctor's appointment today.
-Painful, Red sizable Splotches, Itch/Hot feeling To Touch.  -2 red areas - one around injection site and one below it.
received 2nd vaccine on 2/14/21, on 2/16/21 started having cough, nasal drainage, fatigue. Went to urgent care on 2/23/21 and diagnosed with URI
Extreme soreness at injection site.  Impacts ROM.  Painful to lift left arm above head.  Pain starts below the left AC and extends up to the acromion process.  Intermittent relief when taking OTC pain medications.
Patient is a 39 year old female presents with  Reaction from COVID vaccine #2 Shot was given at  15:23  Reaction  Started 15:43, throat irritation first then vomiting .   No shortness of breath or rashes No fever/chills    Patient had a plastic procedure, injecting filler into her oral lips yesterday.
Nausea; Vomiting; Cramps; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administration date 03Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1, Batch/Lot number: unknown), single for covid-19 immunization. The following information was reported: NAUSEA (non-serious) with onset Mar2021, outcome "unknown", described as "Nausea"; VOMITING (non-serious) with onset Mar2021, outcome "unknown", described as "Vomiting"; MUSCLE SPASMS (non-serious) with onset Mar2021, outcome "unknown", described as "Cramps".  Additional information: When probed for the concern consumer stated that he/she was just reporting that he/she had his/her second dose of Pfizer vaccine (captured as Unspecified medication) on Wednesday (March 3rd), and he/she was fine until last night when he/she experienced nausea, vomiting and cramps.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received on 15-AUG-2017 regarding a case in litigation from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) subcutaneous on or about 14-MAR-2013 as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after being vaccinated, on or about 25-MAR-2013, the was treated by a nurse practitioner at a healthcare facility for the onset of a severe vesicular eruption accompanied by weakened immune symptoms, which was diagnosed as herpes zoster. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Two days after my 2nd moderna shot I started to have pain in my upper left arm , at and above the injection site. a couple of days later a large raised welt developed on my bicep. it was as large as my hand. It last a few days but did fade away. The pain persisted in my upper left arm. some time later I started to feel soreness in my shoulder and the pain lessened. The soreness persisted and then it became more like a burning in my upper bicep. I visited my primary and she prescribed alleve. In a follow up visit she examined me, on 22nd , and recommended PT. She thought it was an impignment in my shoulder. I started physical therapy on June 24th. At that session the Therapist thought it to be a nerve issue causing loss of range of motion. I would get a severe burning sensation in my upper bicep , sometimes spreading to the entire bicep. Started some light exercise making sure to keep my arm in the painfree range of motion.
Needle was in the patients arm. When I went to inject the medication. It spilled out of the syringe. It appeared to leak from the spring mechanism in the safety mechanism of the syringe. Unsure if patient received any of the medication or not
2 wks p/vax pt became weak, tired, anorexic, devel fever, cough, pneumonia; progressing to death;
Fever; neck ache; diarrhea; Ache; Headache; she felt kind of sick and was up a lot of the night; nauseated/nausea; This is a spontaneous report from a contactable consumer (patient) from medical information team. A 66-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, in right arm, on 26Feb2021 08:30 at the age of 66-years-old at dose 2, single for covid-19 immunization. Medical history included bipolar disorder and high cholesterol. The patient had no family medical history. Concomitant medications included ongoing PROZAC, ongoing WELLBUTRIN taken for bipolar disorder, and CRESTOR for cholesterol. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, on 05Feb2021 at the age of 66-years-old at dose 1, single for covid-19 immunization. The patient also received a flu shot and PNEUMOCOCCAL VACCINE at the same time on an unspecified date and her arm felt like it was going to fall off and flu like symptoms. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient has not been tested with covid-19 since the vaccination. The patient experienced nausea, ache, headache, and she felt kind of sick and was up a lot of the night (as reported) on 26Feb2021, diarrhea on 01Mar2021, fever, and neck ache on an unspecified date. The patient underwent lab tests and procedures which included high cholesterol, Vitamin D with unknown results on an unspecific date. Therapeutic measures were taken for headache included Tylenol and was not working. The outcome of the event ache and headache was recovering, nausea, and diarrhea was not recovered, outcome of other events was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml).    No concomitant medications were provided. No treatment medication was provided. This case contains information for the 11th of 17 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-707980 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-707980:Case for patient 1
On 6-30-2022, participant was taken to have routine labwork. On 7-6. her doctor called me to inform me of a low platelet count. Participant had a normal cycle that started the day before labwork but it was not of a heavy flow nature. The doctor has referred participant to a hematologist and that appointment is not scheduled yet at this time. No symptoms have been noted.
Patient was given PREVNAR 13 twice respectively on 1/14/2017 and 1/17/2018 patient said no adverse effect per conversation with PharmD.
After second shot, could not get her blood sugars below 400; headache; had a stomach virus; sleepy; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old female patient received BNT162B2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 19Apr2021 09:30 (age at vaccination: 60-year-old) as second dose, single for covid-19 immunization. Medical history included ongoing type 2 Diabetes (she had it for about 6 years) and high blood pressure from Apr2021 and ongoing, ongoing depression (she had it since she was a teenager), kidney removed from 06Jul2020 to an unknown date, ongoing blood cholesterol, and ongoing bad allergies. Historical vaccine included BNT162B2 on 29Mar2021 (at the age of 60 years, Dose: 1, Time: 09:30, anatomical location: left arm) for covid-19 immunization. Concomitant medication included montelukast sodium (SINGULAIR); pravastatin; venlafaxine hydrochloride (EFFEXOR) at 150 mg taken for depression, start and stop date were not reported; losartan potassium (COZAAR) at 100 mg taken for high blood pressure from Mar2021 to an unspecified stop date. it was reported that After the second shot, she was feeling wonderful, but since then she can not get her sugars below 400. On 14Jun2021 morning she drank. She had breakfast like she was supposed to. She drank tea. She put 1/4 cup sugar per gallon in the tea. Her blood sugar was 311. she stated that she had seen the diabetic doctor regularly. She talked to lots of friends who are diabetic and other people who couldn't get their sugars down, she contacted friends and on looked on social media and they were having the same problem. she stated that she felt like a guinea pig. she went to the doctor after about 2 days. She did not know the dated. She told the doctor that she was dying. The doctor told her that her body was responding to the vaccine. She was sent home. She was told to drink plenty of liquids and rest. she stated that she did not have any treatment for her high sugars. She was watching what she ate. She added that she thought she had a stomach virus. She drank tea. She got sleepy. She had a headache. Her blood sugar was 311 this morning. she stated that her blood sugars were over 300 about 2 weeks after getting the second shot. She complained to her doctor and her diabetes doctor about the sugars. They wanted to put her on medications she could not take. This had never done this before. She cannot get her blood sugars down. It happened since she took the vaccine. She said her friends cannot get blood sugars below 300. The patient underwent lab tests and procedures which included blood sugar: 311 on 14Jun2021. The outcome for the event After second shot, could not get her blood sugars below 400 was reported as not resolved and for remaining events was unknown.  Information about batch/Lot number has been requested.
48yr old female with history of anxiety, previous episodes of arm and leg weakness currently undergoing work-up for intermittent neurologic symptoms x 2yrs (on , allergies (insect venom: hives, shortness of breath; poison ivy:  hives, shortness of breath; sulfa:  hives) presented for COVID-19 J&J vaccine on 4/8/21.  RN administered JANSSEN COVID19 VACC (LOT # 207A21A, exp 6/23/21) IM in patient's left deltoid at 1410.  Approximately 5 minutes after receiving vaccine, patient complained of dizziness which later manifested as increased fatigue, malaise, weakness of the extremities with eventual report of tingling in the face.  Patient unable to ambulate.  Patient transported to exam room via wheelchair and transferred
Pt awoke on 2/8 feeling tired and weak. On 2/9 patient developed fever to 102 and shortness of breath and vomiting.  Was seen in ER and admitted for presumed UTI as well as small PE.
some injection site pain; fatigue; Initial information received on 22-Sep-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (non-healthcare professional).  This case is linked to case 2023SA294491(CLUSTER).  This case involves 64 years female patient who had some injection site pain and fatigue after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (formulation, strength, dosage, expiry date, lot number- not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation). Information on the batch number was requested.  On an unknown date, (unknown latency), the patient developed some injection site pain (vaccination site pain) and fatigue following the administration of influenza vaccine. Caller did not specify which flu vaccines she received in the past.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for both the events.
12 hours after injection? extreme tiredness  20 hours after injection? body aches 28 hours after injection? large lump under right arm where lymph node is located. Lump is EXTREMELY painful.
This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). A female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 30Mar2021 (Batch/Lot number: unknown) as dose 2, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunisation. The following information was reported: ORAL MUCOSAL BLISTERING (non-serious) with onset Apr2021, outcome "not recovered", described as "blisters a week later inside and outside of her mouth"; TONGUE DISCOMFORT (non-serious) with onset Apr2021, outcome "not recovered", described as "Her tongue feels raw, like it was burned"; BACK PAIN (non-serious), RENAL PAIN (non-serious) all with onset Apr2021, outcome "not recovered" and all described as "And she has pain in her back around her kidneys". Additional information: she broke out in blisters a week later inside and outside of her mouth. Her tongue feels raw, like it was burned. And she had pain in her back around her kidneys on both sides. She thought it was going away, but came back even worse. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from an office manager concerning a 32 year old male who on 04-EC-2008 was vaccinated with a dose of PNEUMOVAX (lot #: 660685/0619X). On approximately 04-DEC-2008, within 2 days of giving the vaccine, the patient had fever and a "swollen, red and hot arm". The patient recovered on an unspecified date. The patient contacted office for medical attention. Follow-up information was received from a health professional concerning a 32 year old white male who in 04-DEC-2008 morning was vaccinated SC with the first dose of PNEUMOVAX (lot #: 660685/0619X) into the left arm. In the morning of 05-DEC-2008 the patient developed fever 102.9, swollen arm, body body arch and warm at the site of injection. The patient sought medical attention by doctor visit. This is one of several reports received from the same source. No further information is expected.